Ceftizoxime
- Generic Name
- Ceftizoxime
- Brand Names
- Cefizox
- Drug Type
- Small Molecule
- Chemical Formula
- C13H13N5O5S2
- CAS Number
- 68401-81-0
- Unique Ingredient Identifier
- C43C467DPE
Overview
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Background
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Indication
Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria.
Associated Conditions
- Bacterial Infections
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2011/05/04 | Phase 4 | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
Ceftizoxime Sodium for Injection | 国药准字H20103125 | 苏州中化药品工业有限公司 | 注射剂 | N/A | 0.5g(按C₁₃H₁₃N₅O₅S₂计) | Chemical Drug | Approved | 2020/02/26 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20173313 | 海南葫芦娃药业集团股份有限公司 | 注射剂 | N/A | 1.0g(按C13H13N5OS2计） | Chemical Drug | Approved | 2022/08/01 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20113440 | 苏州中化药品工业有限公司 | 注射剂 | N/A | 1.0g(按C₁₃H₁₃N₅O₅S₂计) | Chemical Drug | Approved | 2020/02/26 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20041918 | 哈药集团制药总厂 | 注射剂 | N/A | 按C13H13N5O5S2计1.5g | Chemical Drug | Approved | 2020/10/12 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20249278 | 重庆科瑞制药（集团）有限公司 | 注射剂 | N/A | 0.5g（按C₁₃H₁₃N₅O₅S₂计） | Chemical Drug | Approved | 2024/11/05 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20249268 | 重庆吉斯瑞制药有限责任公司 | 注射剂 | N/A | 0.5g（按 C₁₃H₁₃N₅O₅S₂计） | Chemical Drug | Approved | 2024/11/05 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20249220 | 海南全星制药有限公司 | 注射剂 | N/A | 0.5g（按C₁₃H₁₃N₅O₅S₂计） | Chemical Drug | Approved | 2024/10/29 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20249249 | 沈阳三九药业有限公司 | 注射剂 | N/A | 1.0g（按C₁₃H₁₃N₅O₅S₂计） | Chemical Drug | Approved | 2024/11/05 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20253050 | 沈阳三九药业有限公司 | 注射剂 | N/A | 1.0g(按C₁₃H₁₃N₅O₅S₂计) | Chemical Drug | Approved | 2025/01/02 | Domestic |
Ceftizoxime Sodium for Injection | 国药准字H20253049 | 沈阳三九药业有限公司 | 注射剂 | N/A | 0.5g(按C₁₃H₁₃N₅O₅S₂计) | Chemical Drug | Approved | 2025/01/02 | Domestic |
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug